ferric oxide Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
4443 1309-37-1

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • iron oxide
  • ferric oxide
  • ferric oxide red
  • ferric oxide, saccharated
  • iron oxide, nanoparticles
A glucaric acid-iron conjugate that is used in the treatment of IRON-DEFICIENCY ANEMIA, including in patients with chronic kidney disease, when oral iron therapy is ineffective or impractical.
  • Molecular weight: 159.69
  • Formula: Fe2O3
  • CLOGP:
  • LIPINSKI: None
  • HAC: 3
  • HDO: 0
  • TPSA: 43.37
  • ALOGS:
  • ROTB: 2

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
None FDA

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

Pharmacologic Action:

SourceCodeDescription
ATC V08CB03 VARIOUS
CONTRAST MEDIA
MAGNETIC RESONANCE IMAGING CONTRAST MEDIA
Superparamagnetic contrast media
MeSH PA D006397 Hematinics
MeSH PA D006401 Hematologic Agents

Drug Use (View source of the data)

DiseaseRelationSNOMED_IDDOID
Proctitis indication 3951002 DOID:3127
Wound indication 13924000
Anemia of prematurity indication 47100003 DOID:11243
Burn injury indication 48333001
Hemorrhoids indication 70153002 DOID:9746
Rectal pain indication 77880009
Iron deficiency anemia indication 87522002
Eruption of skin indication 271807003 DOID:0050486
Arthropod bite wound indication 409985002
Itching of skin indication 418363000
Hemosiderosis contraindication 39011001 DOID:12119
Low blood pressure contraindication 45007003
Chronic Iron Overload contraindication

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D04616 KEGG_DRUG
4020222 VUID
N0000179132 NUI
4020161 VANDF
4020162 VANDF
4020222 VANDF
4021278 VANDF
C0060240 UMLSCUI
CHEBI:82530 CHEBI
CHEMBL2108514 ChEMBL_ID
DB11576 DRUGBANK_ID
D000077605 MESH_DESCRIPTOR_UI
C000499 MESH_SUPPLEMENTAL_RECORD_UI
1K09F3G675 UNII
91663255 PUBCHEM_CID
1310572 RXNORM
15814 MMSL
NOCODE MMSL
d04725 MMSL
006622 NDDF
006623 NDDF
007471 NDDF
008975 NDDF
129497004 SNOMEDCT_US
387206004 SNOMEDCT_US
421953007 SNOMEDCT_US

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Caladryl HUMAN OTC DRUG LABEL 3 0187-5465 LOTION 1.36 mg TOPICAL OTC monograph final 14 sections
BABY ANTI MONKEY BUTT DIAPER RASH HUMAN OTC DRUG LABEL 2 0295-8942 CREAM 0.02 g TOPICAL OTC MONOGRAPH NOT FINULLL 12 sections
Calamine HUMAN OTC DRUG LABEL 2 0363-0224 LOTION 8 g TOPICAL OTC monograph final 14 sections
Walgreens CalamineSkin Protectant HUMAN OTC DRUG LABEL 2 0363-4360 LOTION 8 mL TOPICAL OTC monograph final 12 sections
Calamine Plus Pramoxine HCl HUMAN OTC DRUG LABEL 3 0363-8588 AEROSOL, SPRAY 0.35 mg TOPICAL OTC monograph not final 12 sections
Calamine HUMAN OTC DRUG LABEL 3 0363-9114 LOTION 8.60 mg TOPICAL OTC monograph final 12 sections
Henry Schein Flexible Unna Boot with Calamine HUMAN OTC DRUG LABEL 2 0404-0010 DRESSING 0.02 g TOPICAL OTC monograph final 9 sections
Henry Schein Flexible Unna Boot with Calamine HUMAN OTC DRUG LABEL 2 0404-0011 DRESSING 0.02 g TOPICAL OTC monograph final 9 sections
Calamine HUMAN OTC DRUG LABEL 2 0869-0063 LOTION 80 mg TOPICAL OTC monograph final 12 sections
Calamine HUMAN OTC DRUG LABEL 3 0869-0336 LOTION 8.60 mg TOPICAL OTC monograph not final 12 sections
Calamine HUMAN OTC DRUG LABEL 2 0904-2533 LOTION 8 g TOPICAL OTC MONOGRAPH FINULLL 13 sections
Calamine HUMAN OTC DRUG LABEL 2 11673-063 LOTION 8 g TOPICAL OTC monograph final 13 sections
Calamine Plus Pramoxine HCl HUMAN OTC DRUG LABEL 3 11673-635 AEROSOL, SPRAY 0.35 mg TOPICAL OTC monograph not final 12 sections
LanoguardMulti-Purpose HUMAN OTC DRUG LABEL 3 12090-0061 OINTMENT 20 mg TOPICAL OTC monograph final 11 sections
TENDERWRAP HUMAN OTC DRUG LABEL 2 12823-401 DRESSING 0.02 g TOPICAL OTC monograph final 7 sections
Calamine HUMAN OTC DRUG LABEL 2 21130-941 LOTION 8 g TOPICAL OTC monograph final 12 sections
Cellzyme ON-TOX HUMAN OTC DRUG LABEL 3 24765-111 CREAM 0.08 g TOPICAL OTC monograph not final 8 sections
Unnaplast with Calamine HUMAN OTC DRUG LABEL 2 28691-1005 DRESSING 0.15 mg TOPICAL OTC monograph final 9 sections
Calamine HUMAN OTC DRUG LABEL 2 30142-063 LOTION 8 g TOPICAL OTC monograph final 13 sections
Calamine Plus Pramoxine HCl HUMAN OTC DRUG LABEL 3 30142-156 AEROSOL, SPRAY 0.35 mg TOPICAL OTC monograph not final 12 sections
MAYINGLONG BEZORNIL HEMORRHOIDAL HUMAN OTC DRUG LABEL 4 30803-001 OINTMENT 0.05 g TOPICAL OTC monograph final 15 sections
Calamine HUMAN OTC DRUG LABEL 2 36800-063 LOTION 80 mg TOPICAL OTC monograph final 12 sections
Calamine HUMAN OTC DRUG LABEL 3 36800-336 LOTION 8.60 mg TOPICAL OTC monograph final 12 sections
Calamine Plus Pramoxine HCl HUMAN OTC DRUG LABEL 3 36800-398 AEROSOL, SPRAY 0.35 mg TOPICAL OTC monograph not final 11 sections
Calamine HUMAN OTC DRUG LABEL 3 41163-009 LOTION 8.60 mg TOPICAL OTC monograph final 11 sections
Calamine HUMAN OTC DRUG LABEL 2 41190-063 LOTION 80 mg TOPICAL OTC monograph final 12 sections
Calamine Plus Pramoxine HCL HUMAN OTC DRUG LABEL 3 41250-235 AEROSOL, SPRAY 0.35 mg TOPICAL OTC monograph not final 11 sections
Calamine HUMAN OTC DRUG LABEL 3 41250-888 LOTION 0.80 mg TOPICAL OTC monograph final 11 sections
Calamine HUMAN OTC DRUG LABEL 2 41520-063 LOTION 8 g TOPICAL OTC monograph final 12 sections
Calamine Plus Pramoxine HCl HUMAN OTC DRUG LABEL 3 41520-184 AEROSOL, SPRAY 0.35 mg TOPICAL OTC monograph not final 13 sections